Low Molecular Weight Iron Dextran Increases Fibroblast Growth Factor-23 Concentration, Together With Parathyroid Hormone Decrease in Hemodialyzed Patients
Therapeutic Apheresis and Dialysis, 04/23/2012
Hryszko T et al. – The study highlights a pathophysiological element, which may connect suppression of parathyroid glands with intravenous iron supplementation.



